Stanozolol Injection - Genesis | 10 ml | 50 mg/ml is a premium pharmaceutical-grade aqueous suspension of stanozolol, a dihydrotestosterone (DHT) derived anabolic-androgenic steroid. Engineered by Genesis, this compound is renowned among competitive bodybuilders and track athletes for promoting dense, vascular, and dry muscle tissue without subcutaneous water retention. Stanozolol exhibits a high anabolic-to-androgenic ratio (320:30), allowing athletes to build lean mass, boost nitrogen retention, and drastically lower Sex Hormone-Binding Globulin (SHBG) levels, thereby amplifying the bioavailability of concurrent anabolic compounds.
Unlike oil-based preparations, injectable stanozolol bypasses immediate hepatic clearance, offering high biological utilization. Key clinical and physiological benefits include:
Due to its microcrystalline aqueous suspension form, Stanozolol Injection Genesis requires careful administration. The vial must be shaken thoroughly before aspiration to ensure an even distribution of crystals.
In cutting cycles, Stanozolol combines synergistically with non-aromatizing agents such as Drostanolone (Masteron) or Trenbolone Acetate for competition-level hardness. To prevent joint dryness and maintain hormonal equilibrium, a physiological base of Testosterone Propionate is strongly advised.
Because stanozolol is 17-alpha-alkylated even in its injectable form, liver support (such as TUDCA or NAC) and regular lipid monitoring are essential. Post Cycle Therapy (PCT) with SERMs like Clomiphene (Clomid) and Tamoxifen (Nolvadex) should commence 48 to 72 hours after the final injection.
Because of its aqueous suspension active half-life of approximately 24 hours, Stanozolol Injection is most effectively dosed either daily (50 mg/day) or every other day (50-100 mg EOD) to maintain stable plasma concentrations.
Yes. Injectable stanozolol remains a 17-alpha-alkylated steroid. While it avoids the immediate first-pass effect associated with oral tablets, it still exerts metabolic stress on the liver, requiring cycle lengths capped at 6-8 weeks and liver protection supplements.
Vigorously shake the vial to fully suspend the micro-crystals, use an appropriate gauge needle (22G to 25G), warm the vial slightly in warm water before drawing, and rotate injection sites frequently.
